MYOV - Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q3 2020 Results - Earnings Call Transcript

Myovant Sciences Ltd. (MYOV) Q3 2020 Earnings Conference Call February 11, 2021, 08:30 AM ET Company Participants Ryan Crowe - Vice President of Investor Relations Dave Marek - Chief Executive Officer Frank Karbe - President & Chief Financial Officer Adele Gulfo - Interim Chief Business and Commercial Development Office Juan Camilo Arjona - Chief Medical Officer Conference Call Participants Jason Butler - JPM Securities Phil Nadeau - Cowen Eric Joseph - JPMorgan Paul Choi - Goldman Sachs Mohit Bansal - Citi Ami Fadia - Leerink Presentation Operator Good day, everyone and welcome to Myovant Sciences Third Fiscal Quarter 2020 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Ryan Crowe, Vice President of Investor Relations at Myovant. Please go ahead. Ryan Crowe Thank you, Operator. Good morning and thanks for joining us today for a general business update and

For further details see:

Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q3 2020 Results - Earnings Call Transcript